ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO 2023 Insights: "Phase 3 LIBRETTO-531 Study - Selpercatinib for Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer"
By
ecancer
FEATURING
Julien Hadoux
By
ecancer
FEATURING
Julien Hadoux
Login to view comments.
Click here to Login
